NCT02071602View on ClinicalTrials.gov

CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

November 30, 2018

Conditions

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Interventions

DRUG

CD-NP

Randomized 1:1:1

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER